SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD

Review checklist: Audre Lorde (HR-ML016)
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
- 11judgment calls in the dossier
- 1protocol deviations
- 5orders and referrals without results in the record
- 0evidence items to check (retrospective or sensitive claims, unconfirmed diagnoses)
Review status
| Review | Status | Reviewer | Date | Notes |
|---|
| schema validation | not_started | | | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | | | Awaiting clinician review; check the tamoxifen-alone decision, the surveillance plan, and the timing of genetic assessment. |
| provenance review | not_started | | | Recent-death rule: only what Lorde published about her own illness, as reported by the Academy of American Poets, the Spelman College Archives finding aid, a published foreword to The Cancer Journals, reference biographies, and a review of A Burst of Light. Tumor details and all treatment besides the mastectomy are synthetic. |
| safe messaging review | not_started | | | No behavioral-health diagnosis; her identity is described only as her own work and the cited sources describe it; her decisions about a prosthesis and later treatment are recorded as her own; death recorded without detail. |
Judgment calls (dossier editorial resolutions)
- Recent-death rule. Lorde died in 1992. The case uses only what she published about her own illness, as her archive's finding aid, a published foreword to The Cancer Journals, reference biographies, and a review of A Burst of Light report it, with basic biographical facts. The full texts of The Cancer Journals and A Burst of Light could not be read (the library copies are access-restricted), so only facts and short quotations that appear in the fetched sources are used. No medical records, accounts by relatives or friends, or speculation about undisclosed conditions are used. The recent-death review rule applies.
- What is documented and what is synthetic. Documented (D): the benign breast tumor of 1977, the right breast lump found on Labor Day 1978, the diagnosis of breast cancer and the mastectomy that year, her refusal of a prosthesis, the liver spread in 1984 and her choice of alternative treatment rather than more surgery, and her death in 1992. Everything else in the modern episode is synthetic (S): the tumor size, grade, receptor status, recurrence score, and stage; the sentinel node biopsy; tamoxifen and its side effects; every score, vital sign, and laboratory value; the genetic counseling; and the preventive care. No source gives her tumor's biology or any treatment besides the mastectomy, and none is implied. The synthetic findings were kept low-risk and mild (minimal PHQ-9 and GAD-7 scores, mild hot flashes managed without medicine, normal screening results) so that nothing reads as a claim about her private health.
- Diagnosis year. The foreword to The Cancer Journals and the Spelman finding aid place the diagnosis and mastectomy in 1978, and the finding aid dates the liver diagnosis six years later, in agreement with the 1984 date in Publishers Weekly. The National Women's History Museum gives 1977 as the year of diagnosis; the 1977 event documented elsewhere is a tumor that proved benign. The case uses 1978 for the cancer and records the 1977 tumor as benign.
- Her decisions. Her refusal of a prosthesis is documented in her own words and is recorded as her considered choice. The synthetic patient chose a flat closure without reconstruction and does not wear an external prosthesis; every note records this without pressing it, and the consultant records it as respected. Her later choice of alternative treatment for the liver disease is recorded only as a claim, without comment, and plays no part in the episode. Reports that she was treated at a clinic in Switzerland with a mistletoe preparation appear in a library catalog description and secondhand excerpts that could not be fetched or verified, so they are not used.
- Identity. She is described as a poet, essayist, and novelist who wrote as a Black lesbian woman, a mother, and a feminist, in the words of the cited sources. The synthetic social history says she lives with her partner and her two teenage children; the partner is unnamed, gives no history, and is not a source of any statement. Her children are not named.
- Quotations. Two short quotations of Lorde are used, each as it appears in a fetched source: "wad of lambswool pressed into a pale pink breast-shaped pad" (quoted in the foreword) and "Your silence will not protect you" (quoted in The Marginalian). No other words are attributed to her. "Morale" is the foreword's quotation of the book.
- Index age. The modern episode presents her at 45, five and a half months after the mastectomy, in the survivorship period she wrote about in The Cancer Journals. The synthetic date of birth is February 18, 1981 (shift 47 years). The index visit on March 9, 2026 maps to March 9, 1979; the chronic-care visits on March 30, June 29, and September 28, 2026 and the preventive visit on October 19, 2026 map to the same days of 1979, all before the liver diagnosis of 1984. The synthetic diagnostic imaging, biopsy, and mastectomy are dated September 2025 (true frame September 1978), after Labor Day, to agree with the documented sequence; their exact days are synthetic, because no fetched source gives the date of the operation. Past medical history includes only the 1977 and 1978 events; family history is left empty because no fetched source covers it and the recent-death rule applies.
- Preventive visit. An adult preventive visit (age 45, so `preventive_adult`) was added on October 19, 2026 (true frame October 19, 1979). No sick visit was added, under the recent-death rule. Judgment calls: (1) the health risk assessment and the AUDIT-C of 1 (a glass of wine a few times a month) are synthetic and are not drawn from any source; (2) the cervical sample, the hepatitis B, hepatitis C, and HIV tests, and the fecal immunochemical test are ordered with no results recorded; (3) advance care planning records an unnamed health care agent and only general priorities (complete information and making her own decisions, which echo her documented stance), and deliberately records no treatment preference.
- Focused visits. The three chronic-care follow-ups (three weeks, sixteen weeks, and twenty-nine weeks after the first visit) are documented as focused visits on the CMID breast cancer monograph, and each lists every item the protocol calls for at that point, with its interval and status, including the items it does not call for (routine laboratory tests, tumor markers, distant imaging, DXA on tamoxifen alone, and echocardiography without trastuzumab). One protocol deviation is recorded: germline testing, indicated at diagnosis at 44, was not offered by her previous care team. It was found at intake and is recorded at the consultation visit with the corrective action, a genetic counseling request. The waiting list delayed counseling until early October; this is recorded at each visit, and the panel result is still pending at the end of the episode, so no germline result is recorded.
- Consultation. The medical oncology referral and the consultation by Beatriz Lozano, MD (a fictional consultant), on the day of the second visit, are S. The consultant answers the five referral questions with what the record shows happened afterwards: tamoxifen alone continued, with no ovarian suppression or chemotherapy; non-drug measures for hot flashes, with venlafaxine held in reserve and never needed; the yearly left mammogram in September and no routine blood tests or imaging; genetic counseling, which took place in October; and primary care visits every three months with oncology review twice a year.
- Not used. Her journal entries, her talks other than the 1977 talk, her later years on St. Croix, and accounts by friends and family were not used. Her height is not recorded in a fetched source; the 168 cm in the record is synthetic.
Protocol deviations
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|
2026-03-30 Progress note 02 (C-CDA) | Germline genetic testing at diagnosis, for breast cancer diagnosed at 65 or younger | Once, at diagnosis | Not offered at diagnosis by her previous care team, a deviation from the guideline found at intake. No harm is known: the result would not have changed her surgery, which she chose, but it could change surveillance and the advice to relatives. Corrective action: genetic counseling requested today, as Dr. Lozano advised |
Orders and referrals without results in the record
| Visit | Type | Item | Status | Detail |
|---|
2026-03-30 Progress note 02 (C-CDA) | Referral | Genetic counseling | Referred | Request sent today; on the waiting list |
2026-06-29 Progress note 03 (C-CDA) | Referral | Genetic counseling | Referred | Still on the waiting list three months after the request; first appointment early October. The clinic coordinator was asked to offer any earlier cancellation. No result is needed for her current care |
2026-09-28 Progress note 04 (C-CDA) | Referral | Genetic counseling | Referred | Appointment next week |
2026-10-19 Progress note 05 (C-CDA) | Prevention | Colorectal cancer screening | Ordered | Recommended from 45; after discussing the options she chose a yearly fecal immunochemical test; kit given |
2026-10-19 Progress note 05 (C-CDA) | Prevention | Hepatitis B, hepatitis C, and HIV screening | Ordered | One-time screening; no prior result on record; drawn today, results pending |
Evidence to check
Retrospective claims (R)
None.
Sensitive claims
None.
Diagnoses not confirmed
None.
Notes to read
Every note in the record, with its type. All clinical content is synthetic.
Abnormal results
None.